Alexander N Shoushtari (Alexander Shoushtari)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 49

Top Topics

Liver Metastases

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

Pigment cell & melanoma research

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph J Sacco, Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason John Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Chris Holland, Takami Sato
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
Joseph J Sacco, Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason John Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Chris Holland, Takami Sato
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Joseph J Sacco, Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason John Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Chris Holland, Takami Sato
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sarah E Lochrin, Darren J Buonocore, Robert J Young, Thomas J Kaley, Michael A Postow, Jedd D Wolchok, Alexander N Shoushtari, Parisa Momtaz, Allison S Betof Warner, Margaret K Callahan
Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab. Pigment cell & melanoma research (2024)
Leila Haghani, Chenyang Zhan, Hooman Yarmohammadi, Etay Ziv, Vlasios S Sotirchos, Debkumar Sarkar, Alexander N Shoushtari, Joseph Patrick Erinjeri
Immunotherapy and transarterial embolization in patients with metastatic melanoma: a retrospective cohort study. Immunotherapy (2024)
Joseph J Sacco, Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason John Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Chris Holland, Takami Sato
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Joseph J Sacco, Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason John Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Chris Holland, Takami Sato
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Alexander Z Wei, Lanyi N Chen, Marlana Orloff, Charlotte E Ariyan, Maryam Asgari, Christopher A Barker, Elizabeth I Buchbinder, Sunandana Chandra, Kasey Couts, Michael M Frumovitz, Andrew Futreal, Jeffrey E Gershenwald, Ehab Y Hanna, Benjamin Izar, Amy K LeBlanc, Mario M Leitao, Evan J Lipson, David Liu, Martin McCarter, Jennifer L McQuade, Yana Najjar, Suthee Rapisuwon, Sara Selig, Alexander N Shoushtari, Iwei Yeh, Gary K Schwartz, Jun Guo, Sapna Pradyuman Patel, Richard D Carvajal
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA). Pigment cell & melanoma research (2023)
Rodabe N Amaria, Michael Postow, Elizabeth M Burton, Michael T Tetzlaff, Merrick I Ross, Carlos A Torres-Cabala, Isabella C Glitza Oliva, Fei Duan, Denái R Milton, Klaus J Busam, Lauren Simpson, Jennifer Leigh McQuade, Michael K Wong, Jeffrey E Gershenwald, Jeffrey E Lee, Ryan P Goepfert, Emily Z Keung, Sarah B Fisher, Allison Betof Warner, Alexander N Shoushtari, Margaret K Callahan, Daniel Coit, Edmund K Bartlett, Danielle Bello, Parisa Momtaz, Courtney Nicholas, Aidi Gu, Xuejun Zhang, Brinda Rao Korivi, Madhavi Patnana, Sapna Pradyuman Patel, Adi Diab, Anthony Lucci, Victor G Prieto, Michael A Davies, James P Allison, Padmanee Sharma, Jennifer A Wargo, Charlotte Ariyan, Hussein A Tawbi
Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature (2023)
Conor M Prendergast, Kathleen M Capaccione, Egesta Lopci, Jeeban P Das, Alexander N Shoushtari, Randy Yeh, Daniel Amin, Laurent Dercle, Dorine de Jong
More than Just Skin-Deep: A Review of Imaging's Role in Guiding CAR T-Cell Therapy for Advanced Melanoma. Diagnostics (Basel, Switzerland) 13 (5) (2023)
Conor M Prendergast, Kathleen M Capaccione, Egesta Lopci, Jeeban P Das, Alexander N Shoushtari, Randy Yeh, Daniel Amin, Laurent Dercle, Dorine de Jong
More than Just Skin-Deep: A Review of Imaging's Role in Guiding CAR T-Cell Therapy for Advanced Melanoma. Diagnostics (Basel, Switzerland) 13 (5) (2023)
Paul B Chapman, Mark G Klang, Michael A Postow, Alexander N Shoushtari, Ryan J Sullivan, Jedd D Wolchok, Taha Merghoub, Sadna Budhu, Phillip Wong, Margaret K Callahan, Bin Zheng, Jonathan H Zippin
Phase Ib trial of phenformin in patients with V600-mutated melanoma receiving dabrafenib and trametinib. Cancer research communications (2023)
Omid Hamid, Jessica C Hassel, Alexander N Shoushtari, Friedegund Meier, Todd M Bauer, April K S Salama, John M Kirkwood, Paolo Antonio Ascierto, Paul C Lorigan, Cornelia Mauch, Marlana Orloff, Thomas R Jeffry Evans, Chris Holland, Ramakrishna Edukulla, Shaad E Abedin, Mark Ross Middleton
Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study. Journal for immunotherapy of cancer 11 (6) (2023)
Patrick C Demkowicz, Renelle Pointdujour-Lim, Sofia Miguez, Yesung Lee, Bailey S C L Jones, Christopher A Barker, Marcus Bosenberg, David H Abramson, Alexander N Shoushtari, Harriet Kluger, Jasmine H Francis, Mario Sznol, Mathieu F Bakhoum
Determinants of overall survival in patients with metastatic uveal melanoma. Cancer (2023)
Kimberly Loo, Hannah L Kalvin, Katherine S Panageas, Margaret K Callahan, Paul B Chapman, Parisa Momtaz, Alexander N Shoushtari, Jedd D Wolchok, Michael A Postow, Allison Betof Warner
Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1. Pigment cell & melanoma research (2023)
Claire F Friedman, Christine Spencer, Christopher R Cabanski, Katherine S Panageas, Daniel K Wells, Antoni Ribas, Hussein A Tawbi, Katy Tsai, Michael A Postow, Alexander N Shoushtari, Paul B Chapman, Joyson Karakunnel, Samantha Bucktrout, Pier Gherardini, Travis J Hollmann, Richard O Chen, Margaret Callahan, Theresa LaVallee, Ramy Ibrahim, Jedd Wolchok
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses. Journal for immunotherapy of cancer 10 (1) (2022)
Alexander N Shoushtari, Anthony J Olszanski, Marta Nyakas, Thomas J Hornyak, Jedd D Wolchok, Victor Levitsky, Lukasz Kuryk, Thomas Birkballe Hansen, Magnus Jäderberg
Pilot study of ONCOS-102 and pembrolizumab: remodeling of the tumor micro-environment and clinical outcomes in anti-PD1-resistant advanced melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra P Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason J Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Howard M Goodall, Koustubh Ranade, Chris Holland, Shaad E Abdullah, Joseph J Sacco, Takami Sato
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial. Nature medicine 28 (11) (2022)
Paul B Chapman, Vetri Sudar Jayaprakasam, Katherine S Panageas, Margaret Callahan, Michael A Postow, Alexander N Shoushtari, Jedd D Wolchok, Allison Betof Warner
Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab. Journal for immunotherapy of cancer 9 (10) (2022)
Lukas Kraehenbuehl, Aliya Holland, Emma Armstrong, Sirinya O'Shea, Levi Mangarin, Sara Chekalil, Amanda Johnston, John S Bomalaski, Joseph P Erinjeri, Christopher A Barker, Jasmine H Francis, Jedd D Wolchok, Taha Merghoub, Alexander N Shoushtari
Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma. Cancers 14 (11) (2022)
Jeffrey S Weber, Tayla Poretta, Brian D Stwalley, Leon A Sakkal, Ella X Du, Travis Wang, Yan Chen, Yan Wang, Keith A Betts, Alexander N Shoushtari
Correction to: Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival. Cancer immunology, immunotherapy : CII (2022)
James W Smithy, Alexander N Shoushtari
Adjuvant PD-1 Blockade in Resected Melanoma: Is Preventing Recurrence Enough? Cancer discovery 12 (3) (2022)
Nicholas R Kurtansky, Rachel N Manci, Danielle M Bello, Adewole S Adamson, Alexander N Shoushtari, Mackenzie R Wehner, Charlotte E Ariyan, Ashfaq A Marghoob, Michael A Marchetti, Veronica M Rotemberg
Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma. The British journal of dermatology 187 (3) (2022)
Seungyeon Jung, Emma Armstrong, Alexander Z Wei, Fei Ye, Aaron Lee, Matteo S Carlino, Ryan J Sullivan, Richard D Carvajal, Alexander N Shoushtari, Douglas B Johnson
Clinical and genomic correlates of imatinib response in melanomas with KIT alterations. British journal of cancer 127 (9) (2022)
Jeffrey S Weber, Tayla Poretta, Brian D Stwalley, Leon A Sakkal, Ella X Du, Travis Wang, Yan Chen, Yan Wang, Keith A Betts, Alexander N Shoushtari
Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival. Cancer immunology, immunotherapy : CII (2022)
Prachi Bhave, Tasnia Ahmed, Serigne N Lô, Alexander N Shoushtari, Anne Zaremba, Judith M Versluis, Joanna Mangana, Michael Weichenthal, Lu Si, Thierry Lesimple, Caroline Robert, Claudia Trojanello, Alexandre Wicky, Richard Heywood, Lena Tran, Kathleen Batty, Florentia Dimitriou, Anna Stansfeld, Clara Allayous, Julia Katharina Schwarze, Meghan J Mooradian, Oliver Klein, Inderjit Mehmi, Rachel Roberts-Thomson, Andrea Maurichi, Hui-Ling Yeoh, Adnan Khattak, Lisa Zimmer, Christian U Blank, Egle Ramelyte, Katharina C Kähler, Severine Roy, Paolo Antonio Ascierto, Olivier Michielin, Paul C Lorigan, Douglas B Johnson, Ruth Plummer, Celeste Lebbe, Bart Neyns, Ryan J Sullivan, Omid Hamid, Mario Santinami, Grant A McArthur, Andrew M Haydon, Georgina V Long, Alexander M Menzies, Matteo S Carlino
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma. Journal for immunotherapy of cancer 10 (7) (2022)
Rodabe N Amaria, Michael Postow, Elizabeth M Burton, Michael T Tezlaff, Merrick I Ross, Carlos A Torres-Cabala, Isabella C Glitza Oliva, Fei Duan, Denái R Milton, Klaus J Busam, Lauren Simpson, Jennifer Leigh McQuade, Michael K Wong, Jeffrey E Gershenwald, Jeffrey E Lee, Ryan P Goepfert, Emily Z Keung, Sarah B Fisher, Allison Betof Warner, Alexander N Shoushtari, Margaret K Callahan, Daniel Coit, Edmund K Bartlett, Danielle Bello, Parisa Momtaz, Courtney Nicholas, Aidi Gu, Xuejun Zhang, Brinda Rao Korivi, Madhavi Patnana, Sapna Pradyuman Patel, Adi Diab, Anthony Lucci, Victor G Prieto, Michael A Davies, James P Allison, Padmanee Sharma, Jennifer A Wargo, Charlotte Ariyan, Hussein A Tawbi
Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 611 (7934) (2022)
Michael A Postow, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, James W Smithy, Ellesa Naito, Marina K Cugliari, Vladislav Raber, Omar Eton, Suresh G Nair, Katherine S Panageas, Jedd D Wolchok, Paul B Chapman
Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (10) (2021)
Mathieu F Bakhoum, Jasmine H Francis, Albert S Agustinus, Ethan M Earlie, Melody DiBona, David H Abramson, Mercedes Duran, Ignas Masilionis, Elsa Molina, Alexander N Shoushtari, Michael H Goldbaum, Paul S Mischel, Samuel F Bakhoum, Ashley M Laughney
Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression. Nature communications 12 (1) (2021)
Alexander N Shoushtari, Walid K Chatila, Arshi Arora, Francisco Sanchez-Vega, Havish S Kantheti, Jorge A Rojas Zamalloa, Penina Krieger, Margaret K Callahan, Allison Betof Warner, Michael A Postow, Parisa Momtaz, Suresh Nair, Charlotte E Ariyan, Christopher A Barker, Mary Susan Brady, Daniel G Coit, Neal X Rosen, Paul B Chapman, Klaus J Busam, David B Solit, Katherine S Panageas, Jedd D Wolchok, Nikolaus Schultz
Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (8) (2021)
Cristina Valero, Mark Lee, Douglas Hoen, Jingming Wang, Zaineb Nadeem, Neal Patel, Michael A Postow, Alexander N Shoushtari, George Plitas, Vinod P Balachandran, J Joshua Smith, Aimee M Crago, Kara Long Roche, Daniel W Kelly, Robert M Samstein, Satshil Rana, Ian Ganly, Richard J Wong, Abraham Ari Hakimi, Michael F Berger, Ahmet Zehir, David B Solit, Marc Ladanyi, Nadeem Riaz, Timothy A Chan, Venkatraman E Seshan, Luc G T Morris
The association between tumor mutational burden and prognosis is dependent on treatment context. Nature genetics 53 (1) (2021)
Xue Bai, Jiani Hu, Allison Betof Warner, Henry T Quach, Christopher G Cann, Michael Z Zhang, Lu Si, Bixia Tang, Chuanliang Cui, Xiaoling Yang, Xiaoting Wei, Lalit Pallan, Catriona Harvey, Michael P Manos, Olivia Ouyang, Michelle S Kim, Gyulnara Kasumova, Justine V Cohen, Donald P Lawrence, Christine Freedman, Riley M Fadden, Krista M Rubin, Tatyana Sharova, Dennie T Frederick, Keith T Flaherty, Osama E Rahma, Georgina V Long, Alexander M Menzies, Jun Guo, Alexander N Shoushtari, Douglas B Johnson, Ryan J Sullivan, Genevieve Marie Boland
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)
Alexander N Shoushtari
Incorporating VEGF Blockade Into a Shifting Treatment Paradigm for Mucosal Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (8) (2021)
Cristina Valero, Mark Lee, Douglas Hoen, Kate Weiss, Daniel W Kelly, Prasad S Adusumilli, Paul K Paik, George Plitas, Marc Ladanyi, Michael A Postow, Charlotte E Ariyan, Alexander N Shoushtari, Vinod P Balachandran, Abraham Ari Hakimi, Aimee M Crago, Kara C Long Roche, J Joshua Smith, Ian Ganly, Richard J Wong, Snehal G Patel, Jatin P Shah, Nancy Y Lee, Nadeem Riaz, Jingming Wang, Ahmet Zehir, Michael F Berger, Timothy A Chan, Venkatraman E Seshan, Luc G T Morris
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors. Nature communications 12 (1) (2021)
Ronglai Shen, Michael A Postow, Matthew J Adamow, Arshi Arora, Margaret Hannum, Colleen Maher, Phillip Wong, Michael A Curran, Travis J Hollman, Liwei Jia, Hikmat A Al-Ahmadie, Niamh M Keegan, Samuel A Funt, Gopa Iyer, Jonathan E Rosenberg, Dean F Bajorin, Paul B Chapman, Alexander N Shoushtari, Allison Betof Warner, Parisa Momtaz, Taha Merghoub, Jedd D Wolchok, Katherine S Panageas, Margaret K Callahan
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade. Science translational medicine 13 (608) (2021)
Mark Ross Middleton, Cheryl McAlpine, Victoria K Woodcock, Philippa Corrie, Jeffrey R Infante, Neil M Steven, Thomas R Jeffry Evans, Alan Anthoney, Alexander N Shoushtari, Omid Hamid, Avinash Gupta, Antonella Vardeu, Emma Leach, Revashnee Naidoo, Sarah Stanhope, Sion Lewis, Jacob Hurst, Ita O'Kelly, Mario Sznol
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)
Tyler D Hitchman, Gabriella Bayshtok, Emilie Ceraudo, Amanda R Moore, Cindy Lee, Ruobing Jia, Naitao Wang, Mohini R Pachai, Alexander N Shoushtari, Jasmine H Francis, Youxin Guan, Juliet Chen, Matthew T Chang, Barry S Taylor, Thomas P Sakmar, Thomas Huber, Ping Chi
Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (5) (2020)
Jun Li, Mercedes A Duran, Ninjit Dhanota, Walid K Chatila, Sarah E Bettigole, John Kwon, Roshan K Sriram, Matthew Phillip Humphries, Manuel Salto-Tellez, Jacqueline A James, Matthew G Hanna, Johannes C Melms, Sreeram Vallabhaneni, Kevin Litchfield, Ieva Usaite, Dhruva Biswas, Rohan Bareja, Hao Wei Li, Maria Laura Martin, Princesca Dorsaint, Julie-Ann Cavallo, Peng Li, Chantal Pauli, Lee Gottesdiener, Benjamin J DiPardo, Travis J Hollmann, Taha Merghoub, Hannah Y Wen, Jorge S Reis-Filho, Nadeem Riaz, Shin-San Michael Su, Anusha Kalbasi, Neil Vasan, Simon N Powell, Jedd D Wolchok, Olivier Elemento, Charles Swanton, Alexander N Shoushtari, Eileen E Parkes, Benjamin Izar, Samuel F Bakhoum
Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis. Cancer discovery 11 (5) (2020)
Karmela Kim Chan, Cynthia Magro, Alexander N Shoushtari, Charles M Rudin, Veronica M Rotemberg, Anthony Rossi, Cecilia Lezcano, John A Carrino, David Fernandez, Michael A Postow, Arlyn Apollo, Mario E Lacouture, Anne R Bass
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature. The oncologist (2019)
Korey A Jaben, Jasmine H Francis, Alexander N Shoushtari, David H Abramson
Isolated Abducens Nerve Palsy Following Pembrolizumab. Neuro-ophthalmology (Aeolus Press) 44 (3) (2019)
Karmela Kim Chan, Cynthia Magro, Alexander N Shoushtari, Charles M Rudin, Veronica M Rotemberg, Anthony Rossi, Cecilia Lezcano, John A Carrino, David Fernandez, Michael A Postow, Arlyn Apollo, Mario E Lacouture, Anne R Bass
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature. The oncologist 25 (2) (2019)
Robert M Samstein, Chung-Han Lee, Alexander N Shoushtari, Matthew D Hellmann, Ronglai Shen, Yelena Y Janjigian, David A Barron, Ahmet Zehir, Emmet J Jordan, Antonio Omuro, Thomas J Kaley, Sviatoslav M Kendall, Robert J Motzer, A Ari Hakimi, Martin H Voss, Paul Russo, Jonathan Rosenberg, Gopakumar V Iyer, Bernard H Bochner, Dean F Bajorin, Hikmat A Al-Ahmadie, Jamie E Chaft, Charles M Rudin, Gregory J Riely, Shrujal Baxi, Alan L Ho, Richard J Wong, David G Pfister, Jedd D Wolchok, Christopher A Barker, Philip H Gutin, Cameron W Brennan, Viviane Tabar, Ingo K Mellinghoff, Lisa M DeAngelis, Charlotte E Ariyan, Nancy Lee, William D Tap, Mrinal M Gounder, Sandra P D'Angelo, Leonard Saltz, Zsofia K Stadler, Howard I Scher, Jose Baselga, Pedram Razavi, Christopher A Klebanoff, Rona Yaeger, Neil H Segal, Geoffrey Y Ku, Ronald P DeMatteo, Marc Ladanyi, Naiyer A Rizvi, Michael F Berger, Nadeem Riaz, David B Solit, Timothy A Chan, Luc G T Morris
Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nature genetics 51 (2) (2019)
Karim R Saab, Meghan J Mooradian, Daniel Y Wang, Jeewon Chon, Cathy Y Xia, Angelica Bialczak, Kelly T Abbate, Alexander M Menzies, Douglas B Johnson, Ryan J Sullivan, Alexander N Shoushtari
Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapy. Cancer 125 (6) (2018)
Ahmet Zehir, Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae Ryan Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M Devlin, Matthew D Hellmann, David A Barron, Alison M Schram, Meera Hameed, Snjezana Dogan, Dara S Ross, Jaclyn F Hechtman, Deborah F DeLair, JinJuan Yao, Diana L Mandelker, Donavan T Cheng, Raghu Chandramohan, Abhinita S Mohanty, Ryan N Ptashkin, Gowtham Jayakumaran, Meera Prasad, Mustafa H Syed, Anoop Balakrishnan Rema, Zhen Y Liu, Khedoudja Nafa, Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona J Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry A Mullaney, Hikmat Al-Ahmadie, Efsevia Vakiani, Adam A Abeshouse, Alexander V Penson, Philip Jonsson, Niedzica Camacho, Matthew T Chang, Helen H Won, Benjamin E Gross, Ritika Kundra, Zachary J Heins, Hsiao-Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B Thomas, Stuart M Gardos, Dalicia N Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R Feldman, Mrinal M Gounder, A Ari Hakimi, James J Harding, Gopakumar V Iyer, Yelena Y Janjigian, Emmet J Jordan, Ciara M Kelly, Maeve A Lowery, Luc G T Morris, Antonio M Omuro, Nitya Raj, Pedram Razavi, Alexander N Shoushtari, Neerav Shukla, Tara E Soumerai, Anna M Varghese, Rona Yaeger, Jonathan Coleman, Bernard Bochner, Gregory J Riely, Leonard B Saltz, Howard I Scher, Paul J Sabbatini, Mark E Robson, David S Klimstra, Barry S Taylor, Jose Baselga, Nikolaus Schultz, David M Hyman, Maria E Arcila, David B Solit, Marc Ladanyi, Michael F Berger
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature medicine 23 (6) (2017)